Cited by 34Drug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and TreatmentLiver physiology and pathology

Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice

Wang, Ying, Wan, Yumeng, Ye, Guihong, Wang, Pu, Xue, Xiaowen, Wu, Guanzhong, Ye, Boping·2016·European Journal of Pharmaceutical Sciences

Abstract

Adiponectin is an antidiabetic and antiatherogenic adipokine, which plays distinct roles in the balance of energy homoeostasis. As an insulin sensitizing hormone, adiponectin exerts multiple biological effects by the specific receptors (AdipoR1 and AdipoR2), through activation of AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR)α pathways. AdipoRon, an orally active synthetic small-molecule AdipoR agonist, shows very similar effects to adiponectin in vitro and in vivo, which could be a promising therapeutic approach for obesity-related disorders. In view of the regulatory effects of adiponectin or AdipoRon on inflammatory response and energy metabolism, they might be endowed a curative potential for tissue damage. Hence, its effects and possible mechanism were investigated. In vitro studies on hepatocytes (L02) and macrophages (RAW264.7) suggested a protective and anti-inflammatory potential of AdipoRon. The effects were verified in acute hepatic injury mice induced by d-galactosamine (D-GalN): hepatic lesions were restored by AdipoRon or bicyclol (positive reference drug) pretreatment, which were characterized by a significant increase in serological and hepatic biomarkers (AST, ALT, MDA and NOSs). Besides, AdipoRon attenuated the inflammation in the liver, characterized by the dwindling proinflammatory macrophage infiltration, as well as the shrinkage of tumor necrosis factor-α (TNF-α), transforming growth factor beta 1 (TGF-β1), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6); meanwhile conversely promoted AMPK activation by phosphorylation. Combined with liver histopathology, these results demonstrated the hepatoprotective effects of AdipoRon against D-GalN-induced damage, which might be ascribed to the attenuation of inflammation, inhibition of free radical reactions, as well as enhancement of liver energy metabolism.

Integrity signals

Registry

Crossref · 10.1016/j.ejps.2016.08.017

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 79 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wang, Y., Wan, Y., Ye, G., Wang, P., Xue, X., Wu, G., & Ye, B.
Affiliations
  • China Pharmaceutical University (CN)
  • Nanjing Normal University (CN)
Corresponding author
Ye, Boping
Venue
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2016-10
Volume
93
Pages
123-131
ISSN
0928-0987 (ISSN-L)
OpenAlex
W2517176431
Cited by
34
References
79
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 3
FWCI
6.25
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science and Technology Major Projects for Key New Drugs Innovation (2012ZX09103301-018)
  • National Natural Science Foundation of China (30572280, 30801454)
  • Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
AdipoRon, adiponectin, hepatoprotection, D-galactosamine-induced liver injury, acute liver injury, liver inflammation, AMPK, macrophage infiltration, TNF-α, oxidative stress, liver energy metabolism, bicyclol
MeSH terms
Animals, Cell Line, Transformed, Galactosamine, Humans, Liver, Male, Mice, Inbred C57BL, Piperidines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review